AstraZeneca · 3 days ago
Project Management Intern - Chemistry, Manufacturing, and Controls
AstraZeneca is looking for Junior and Masters-level students for a 12-week internship role. The intern will support CMC-focused projects by evaluating costs, resource needs, and timelines while integrating AI predictive tools and collaborating with Biopharmaceutical Development teams.
BiopharmaBiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
Responsibilities
Integrating AI predictive tools to estimate timelines, resourcing, and budget impacts; and assisting with manufacturing cost-of-goods analyses to inform valuation
Working cross-functionally with Biopharmaceutical Development (BPD) teams to consolidate inputs on headcount, vendor needs, funding requirements, and schedule risk, to produce concise, decision-ready summaries aligned to due diligence reports
Providing the intern with CMC project management training, including resourcing models, critical-path scheduling, and understanding governance decisions from due diligence
Qualification
Required
Junior and Masters-level students majoring in Biochemistry, biology, chemistry, bioengineering, data science, or a related field
Candidates must have an expected graduation date after August 2026
Application development skills and proficiency in programming languages such as Python that can be applied to current company integrated software systems
Data analysis and Programming experience such as conducting multi-variable analysis/modeling, and strong proficiency in ML, AI predictive tools and models required
Visualization Tools such as PowerBI required
Understanding of biological, antibodies, and complex data analysis required
Enthusiasm for collaboration, cross-functional projects, public speaking, and presentation design
US Work Authorization is required at time of application
Ability to report onsite to Gaithersburg, MD site 3-5 days per week. This role will not provide relocation assistance
Preferred
CMC experience
Company
AstraZeneca
AstraZeneca is a pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines. It is a sub-organization of Investor.
Funding
Current Stage
Public CompanyTotal Funding
$5.26B2024-07-30Post Ipo Debt· $1.51B
2023-02-28Post Ipo Debt· $2.25B
2023-02-24Post Ipo Debt· $1.5B
Recent News
2026-01-18
Company data provided by crunchbase